703674001: Dapagliflozin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with cellular transport inhibitor mechanism of action (substance)\Sodium glucose cotransporter subtype 2 inhibitor\Dapagliflozin (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Dapagliflozin (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Substance with ether structure\Dapagliflozin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dapagliflozin (substance)	Is a	Sodium glucose cotransporter subtype 2 inhibitor	true	Inferred relationship	Some
Dapagliflozin (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Sodium glucose cotransporter subtype 2 inhibitor (disposition)	true	Inferred relationship	Some
Dapagliflozin (substance)	Is a	Substance with ether structure	true	Inferred relationship	Some
Dapagliflozin (substance)	Is a	A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dapagliflozin propanediol	Is a	False	Dapagliflozin (substance)	Inferred relationship	Some
Product containing dapagliflozin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	1
Dapagliflozin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	1
Dapagliflozin propanediol	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Dapagliflozin (substance)	Inferred relationship	Some
Product containing only dapagliflozin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	1
Product containing only dapagliflozin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	1
Product containing precisely dapagliflozin (as dapagliflozin propanediol monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Dapagliflozin (substance)	Inferred relationship	Some	1
Product containing precisely dapagliflozin (as dapagliflozin propanediol monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Dapagliflozin (substance)	Inferred relationship	Some	1
Product containing dapagliflozin and metformin and saxagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	3
Product containing only dapagliflozin and metformin and saxagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	3
Product containing only dapagliflozin and metformin and saxagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	3
Dapagliflozin- and metformin- and saxagliptin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	3
Dapagliflozin (as dapagliflozin propanediol) 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dapagliflozin (substance)	Inferred relationship	Some	1
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dapagliflozin (substance)	Inferred relationship	Some	1
Allergy to dapagliflozin	Causative agent (attribute)	True	Dapagliflozin (substance)	Inferred relationship	Some	1
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dapagliflozin (substance)	Inferred relationship	Some	2
Dapagliflozin (as dapagliflozin propanediol) 5 mg and metformin hydrochloride 850 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dapagliflozin (substance)	Inferred relationship	Some	2
Product containing dapagliflozin and metformin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	2
Product containing dapagliflozin and metformin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	2
Product containing only dapagliflozin and metformin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	2
Dapagliflozin and metformin only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	2
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 10 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dapagliflozin (substance)	Inferred relationship	Some	2
Product containing only dapagliflozin and saxagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	2
Product containing dapagliflozin and saxagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	2
Product containing only dapagliflozin and saxagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	2
Dapagliflozin- and saxagliptin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dapagliflozin (substance)	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3008942010	Dapagliflozin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3009235014	Dapagliflozin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
365921000195116	dapagliflozin	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
803821000172115	dapagliflozine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
67751000195116	Dapagliflozin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module